I. Neeland

Cardiology and Cardiovascular Medicine · 2012–2023

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom I. Neeland trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Despres
  2. R. Kushner
  3. Peter W. F. Wilson

Who trusts I. Neeland overall

  1. M. Blüher

Papers from I. Neeland's perspective

Ordered by how strongly the researchers I. Neeland trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. (Diabetes Care)
  2. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. (New England Journal of Medicine)
  3. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation (Statistics in Medicine)
  4. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. (New England Journal of Medicine)
  5. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. (New England Journal of Medicine)
  6. A proposed clinical staging system for obesity (International Journal of Obesity)
  7. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. (Archives of Internal Medicine)
  8. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. (European Heart Journal)
  9. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals (Current Opinion in Lipidology)
  10. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. (Clinics in Laboratory Medicine)

Their papers